ARCHIVES

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

International Research Data Bank Up And Operating Through NLM Systems

September 20, 1974

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999